Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2960
https://www.valueinhealthjournal.com/article/S1098-3015(17)33294-1/fulltext
Title :
Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33294-1&doi=10.1016/j.jval.2017.08.2960
First page :
A935
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2710